Literature DB >> 11329449

Detection of heme-binding proteins in epidemic strains of Burkholderia cepacia.

J W Smalley1, P Charalabous, A J Birss, C A Hart.   

Abstract

A panel of 30 previously characterized strains representing five genomovars from the Burkholderia cepacia complex (E. Mahenthiralingam, T. Coenye, J. W. Chung, D. P. Speert, J. R. W. Govan, P. Taylor, and P. Vandamme, J. Clin. Microbiol. 38:910--913, 2000) were examined for their iron protoporphyrin IX-binding ability. These included B. cepacia genomovars I and III and B. stabilis (formerly B. cepacia genomovar IV), B. multivorans (formerly B. cepacia genomovar II), and B. vietnamiensis (formerly B. cepacia genomovar V). Cells were exposed to micro-oxo bisheme of iron protoporphyrin IX (micro-oxo dimers) and examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis under nonreducing, nondenaturing conditions for the presence of heme-binding proteins using tetramethylbenzidine-H(2)O(2) staining. Seven of the 30 strains, each belonging to B. cepacia genomovar III and designated epidemic (in possessing the B. cepacia epidemic strain marker), expressed a 96- to 100-kDa heme-binding protein which was located in the outer membrane. The heme-binding protein of B. cepacia genomovar III epidemic strain C5424 bound iron(III) protoporphyrin IX in both the monomeric and micro-oxo bisheme forms. Cells of all strains grown on Columbia agar bound iron protoporphyrin IX in the micro-oxo bisheme (dimeric) form. There were no statistical differences between the five genomovars, or those possessing the heme-binding protein, in their micro-oxo bisheme-binding ability. Possession of the outer membrane heme-binding protein may be a pathogenicity trait in enabling the bacterium to withstand oxidative stresses in inflammatory exudates in the lung and may aid identification of invasive epidemic strains of B. cepacia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11329449      PMCID: PMC96092          DOI: 10.1128/CDLI.8.3.509-514.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  47 in total

1.  Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis.

Authors:  A R Gessner; J E Mortensen
Journal:  J Med Microbiol       Date:  1990-10       Impact factor: 2.472

Review 2.  Virulence factors of Burkholderia cepacia.

Authors:  J W Nelson; S L Butler; D Krieg; J R Govan
Journal:  FEMS Immunol Med Microbiol       Date:  1994-02

Review 3.  Quelling the red menace: haem capture by bacteria.

Authors:  B C Lee
Journal:  Mol Microbiol       Date:  1995-11       Impact factor: 3.501

4.  Aggregation of ferrihaems. Dimerization and protolytic equilibria of protoferrihaem and deuteroferrihaem in aqueous solution.

Authors:  S B Brown; T C Dean; P Jones
Journal:  Biochem J       Date:  1970-05       Impact factor: 3.857

5.  Cepabactin from Pseudomonas cepacia, a new type of siderophore.

Authors:  J M Meyer; D Hohnadel; F Hallé
Journal:  J Gen Microbiol       Date:  1989-06

6.  Cytochrome c(2) is not essential for photosynthetic growth of Rhodopseudomonas capsulata.

Authors:  F Daldal; S Cheng; J Applebaum; E Davidson; R C Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

7.  Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV).

Authors:  P Vandamme; E Mahenthiralingam; B Holmes; T Coenye; B Hoste; P De Vos; D Henry; D P Speert
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

8.  Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.

Authors:  P Vandamme; B Holmes; M Vancanneyt; T Coenye; B Hoste; R Coopman; H Revets; S Lauwers; M Gillis; K Kersters; J R Govan
Journal:  Int J Syst Bacteriol       Date:  1997-10

9.  Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes.

Authors:  S M Zughaier; H C Ryley; S K Jackson
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

10.  Isolation of a novel siderophore from Pseudomonas cepacia.

Authors:  P A Sokol; C J Lewis; J J Dennis
Journal:  J Med Microbiol       Date:  1992-03       Impact factor: 2.472

View more
  3 in total

1.  The 2-Cys peroxiredoxin alkyl hydroperoxide reductase c binds heme and participates in its intracellular availability in Streptococcus agalactiae.

Authors:  Delphine Lechardeur; Annabelle Fernandez; Bruno Robert; Philippe Gaudu; Patrick Trieu-Cuot; Gilles Lamberet; Alexandra Gruss
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

2.  PAS domain residues and prosthetic group involved in BdlA-dependent dispersion response by Pseudomonas aeruginosa biofilms.

Authors:  Olga E Petrova; Karin Sauer
Journal:  J Bacteriol       Date:  2012-08-24       Impact factor: 3.490

3.  Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo.

Authors:  Tracey A Hunt; Cora Kooi; Pamela A Sokol; Miguel A Valvano
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.